CC
TWST icon

Centiva Capital’s Twist Bioscience TWST Stock Holding History

Centiva Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,651
Closed -$229K – 2611
2024
Q2 		$229K Buy
+4,651
New +$190K ﹤0.01% 1609
2021
Q3 		– Sell
-4,095
Closed -$546K – 1609
2021
Q2 		$546K Buy
+4,095
New +$476K 0.01% 794

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's TWST Position: Q3 2024 in Review

Centiva Capital sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 4,651 shares — an estimated $229K sold.

Centiva Capital first reported a position in TWST in Q2 2021 and held it in 2 quarters. The position peaked at $546K in Q2 2021. 246 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Centiva Capital reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 4,651 Twist Bioscience shares in Q3 2024, an estimated $229K.
  • Centiva Capital first reported a position in Twist Bioscience in Q2 2021 and held it in 2 quarters.
  • Centiva Capital's Twist Bioscience position peaked at $546K in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.